GENE ONLINE|News &
Opinion
Blog

2024-09-02| Asia-Pacific

Core8 Australia, Truongson, and Him Lam Form VIEH Singapore to Drive Investment in Vietnam’s Duc Hoa 3 Industrial Park

by Bernice Lottering
Share To
Him Lam JSC and Truongson Land JSC, in collaboration with Core8 Information Australia Pty Ltd, have formed VIEH Singapore with the aim of transforming Duc Hoa 3 Industrial Park into a high-tech hub for the biotech and semiconductor industries, attracting global leaders and fostering innovation in Vietnam.

Him Lam JSC (Him Lam), Truongson Land JSC (Truongson Land) and Core8 Information Australia Pty Ltd (Core8) with VIEH Singapore have joined forces to enhance Duc Hoa 3 Industrial Park (IP) in Long An province, Vietnam. This collaboration aims to transform the 700-hectare park into a key destination for the biotech and semiconductor industries, attracting global leaders and fostering future innovation in the region.

Vietnam Positions Itself as a Hub for High-tech Industry Advancements

The partnership aims to leverage Core8 Australia‘s expertise in high-tech and biotech sectors, along with VIEH Singapore’s international network, to attract major semiconductor and biotechnology companies, particularly from Taiwan. The goal is to establish Duc Hoa 3 IP as a premier site for these industries, offering access to Vietnam’s growing market.

Duc Hoa 3 IP, strategically located near Ho Chi Minh City, benefits from modern infrastructure and excellent transport links, including proximity to ports, airports, and the Moc Bai border gate. This location supports the establishment of new operations and provides easy access to a skilled workforce.

Leveraging Core8 Australia’s global network and expertise in biotech and high-tech industries, alongside Him Lam and Truongson Land’s operational assets, the partnership aims to attract leading investors and manufacturers. The goal is to position Duc Hoa 3 IP as a premier destination for semiconductor and biotechnology companies, capitalizing on the region’s growth opportunities.

The collaboration presents exciting new prospects for VIEH to engage with international stakeholders and enhance its global footprint. Through the integration of real estate development and technological advancements, the partnership establishes a strong ecosystem for key players in the industry.

Him Lam, Truongson Land and Core8 Australia, with VIEH Singapore are committed to upholding the highest standards of sustainability and corporate responsibility. The development of Duc Hoa 3 IP will include advanced facilities and a supportive investment climate, making it an attractive destination for global companies seeking to expand in Vietnam. This strategic partnership represents a significant milestone in shaping Vietnam’s industrial landscape and driving future investment and innovation.

By integrating real estate development with technology innovation, the partnership aims to build a robust ecosystem that encourages knowledge transfer and cross-border partnerships among industry leaders.

 

By integrating real estate development with technology innovation, the partnership aims to build a robust ecosystem that encourages knowledge transfer and cross-border partnerships among industry leaders.

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Roger Perlmutter’s New Biotech Startup Secures $350 Million in Funding
2025-02-27
Will U.S. ‘s HHS $590 Million Investment Spark a New Era in mRNA Vaccines for Pandemic Flu Threats?
2025-01-22
2024 EU Industrial R&D Investment Scoreboard Highlights 9.8% Increase in R&D Spending
2024-12-30
LATEST
Psychedelics Inching Forward – Psilocybin Therapy Shows Sustained Benefits for Treatment-Resistant Depression
2025-03-24
Healthcare Through the Eyes of AI: Coding the Future of Medicine Through Digital Acceleration
2025-03-21
European Pharmaceutical Review Highlights RNA Therapeutics and Process Analytical Technology in 2025 Issue 1
2025-03-21
Study Examines Long-Term Effects of Anti-Amyloid Drug for Rare Alzheimer’s Variant
2025-03-21
Sanofi Acquires Bispecific Drug Candidate in $600 Million Deal Focused on Autoimmune Disorders
2025-03-21
Trump Administration Policies May Impact Health Care for Intersex Individuals
2025-03-21
Federal Health Care Research Agency Faces Potential Mass Layoffs
2025-03-21
EVENT
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
Scroll to Top